TLR4 and pancreatic neoplasm: A potential mechanism has been proposed in pancreatic cancer, indicating that lipopolysaccharide (LPS) of Gram-negative bacteria triggers an innate immune response that involves recognition by Toll-like receptor 4 (TLR4) and then activate the nuclear factor kB pathway, resulting in chronic inflammation and cancer development (Irfan et al., 2020).